The Singapore Exchange's decision to divest Scientific Beta aligns with its strategic focus on core growth areas, enabling the redeployment of resources towards capabilities that strengthen its multi-asset franchise and long-term growth trajectory. By shedding the unit, SGX can concentrate on investments integral to its securities, derivatives, and data businesses, ensuring a more streamlined and efficient operation. The sale also allows SGX to retain its global multi-asset iEdge platform, continuing to operate and build upon its existing index business. This strategic move demonstrates SGX's commitment to active portfolio management and capital allocation, positioning the exchange for sustained growth and competitiveness in the evolving financial markets.
News From Multiple Perspectives
Supporting SGX's Strategic Focus on Core Growth Areas
Published July 8, 2026 at 1:15 PM UTC